Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S4.09
P/E—
Fwd P/E16.46
PEG1.17
52W— – —
RSI—
Target$376.28 (+36.6%)
Beta0.77
Div1.29%
Loading chart…
RSI ()
Loading patterns…
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 27
Overbought · 100
Signal
Oversold
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
4Bearish
0Neutral
Key Signals 3
▲ Double Bottom
Major reversal
2026-06-25 · $314.63
Two lows ~$294.29 — bullish reversal confirmed
Learn more →
▲ Double Bottom
Major reversal
2026-07-27 · $333.86
Two lows ~$302.94 — bullish reversal confirmed
Learn more →
▼ Double Top
Major reversal
2026-09-01 · $317.62
Two peaks ~$351.13 — bearish reversal confirmed
Learn more →
Momentum Signals 7
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$376.28
+36.6% upside
Low $315
—
High $465
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
65.59%Last 12 Months
Operating Margin
27.02%Last 12 Months
Return on Equity
16.51%Last 12 Months
Revenue Growth
9.40%Year over Year
Free Cash Flow
4.11BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
64.39Most Recent Quarter
Current Ratio
2.16Most Recent Quarter
Cash
3.48BMost Recent Quarter
Total Debt
15.45BMost Recent Quarter
Net Debt
—Most Recent Quarter
How SYK Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 105.70B |
| Enterprise Value | 117.67B |
| Trailing P/E | 28.00 |
| Forward P/E | 16.46 |
| PEG Ratio (5yr) | 1.17 |
| Price/Sales (ttm) | 4.09 |
| Price/Book (mrq) | 4.41 |
| EV/Revenue | 4.55 |
| EV/EBITDA | 15.95 |
Share Statistics
| Avg Vol (3m) | 2.59M |
| Shares Outstanding | 383.57M |
| Float | 348.14M |
| % Held by Insiders | 5.36% |
| % Held by Institutions | 82.84% |
| Short Ratio | 3.27 |
| Short % of Float | 2.08% |
Profitability
| Gross Margin | 65.59% |
| Operating Margin (ttm) | 27.02% |
| Profit Margin | 14.43% |
| Return on Assets (ttm) | 8.16% |
| Return on Equity (ttm) | 16.51% |
Income Statement
| Revenue (ttm) | 25.84B |
| Revenue Growth (yoy) | 9.40% |
| Gross Profit (ttm) | 16.95B |
| EBITDA | 7.38B |
| Net Income (ttm) | 3.73B |
| Diluted EPS (ttm) | 9.84 |
| EPS Growth (yoy) | 44.10% |
Balance Sheet
| Total Cash (mrq) | 3.48B |
| Total Debt (mrq) | 15.45B |
| Debt / Equity (mrq) | 64.39 |
| Current Ratio (mrq) | 2.16 |
| Book Value / Share | 62.54 |
| Operating CF (ttm) | 5.53B |
| Free Cash Flow (ttm) | 4.11B |
Trading & Dividends
| Beta (5Y) | 0.77 |
| 50-Day MA | 325.78 |
| 200-Day MA | 337.14 |
| Fwd Dividend Yield | 1.30% |
| Payout Ratio | 36.06% |
Income
Dividend Yield
1.29%Last 12 Months
Annual Rate
3.52Forward
Payout Ratio
36.06%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 36.06%
Monthly Dividends
Ownership Breakdown
Institutional 82.84%
Insider 5.36%
Public 11.8%
Short Interest
2.08% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in SYK in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|